New clue to ALS and FTD: Faulty protein disrupts brain’s ‘brake’ system
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Jan-2026 14:11 ET (24-Jan-2026 19:11 GMT/UTC)
A new Northwestern University study using patient nervous tissue and lab-grown human neurons has uncovered how a key disease protein, TDP-43, drives overactive nerve cells in the neurodegenerative diseases ALS and frontotemporal dementia (FTD).
The findings not only explain a long-standing mystery of why nerve cells overfire in ALS and FTD but also highlight a promising new drug to slow or prevent disease progression.
MIT researchers designed nanoparticles that can deliver an immune-stimulating molecule called IL-12 directly to ovarian tumors. When given to mice along with checkpoint inhibitors, the treatment eliminated metastatic tumors more than 80 percent of the time.